Liu Yuan, Wu Jiajing, Wu Huijuan, Wang Tianzhan, Gan Hualei, Zhang Xin, Liu Ye, Li Ruixi, Zhao Zhonghua, Chen Qi, Guo Muyi, Zhang Zhigang
Department of Pathology and Key Laboratory of Molecular Medicine, Ministry of Education, Shanghai Medical College, Fudan University, Shanghai 200032, People's Republic of China.
J Pathol. 2009 Apr;217(5):642-53. doi: 10.1002/path.2511.
Ubiquitin C-terminal hydrolase-L1 (UCH-L1), an important member of de-ubiquitination enzyme families involved in the ubiquitin-proteasome pathway, is expressed mainly in neural and reproductive systems as well as in some tumours. Recently, expression of UCH-L1 has been discovered in parietal epithelial cells of Bowman's capsules and some tubular epithelia in the kidney. However, whether UCH-L1 is expressed in the capillary tufts of the glomeruli has not yet become clear. In this study, we used immunohistochemistry, double immunofluorescence labelling, immunoelectron microscopy in kidney biopsy tissues and western blot in cultured rat podocytes to investigate the expression of UCH-L1 and the regulation of this expression in podocytes. The results demonstrated that UCH-L1 was expressed in podocytes and its expression was significantly higher in acute proliferative glomerulonephritis (APGN), lupus nephritis (LN), membranous glomerulonephritis (MGN) and IgA nephropathy than that in focal segmental glomerulosclerosis (FSGS), minimal change disease (MCD), minor abnormality and normal kidney tissues (p < 0.05). In in vitro experiments, western blot showed that UCH-L1 expression significantly increased in the two groups of podocytes co-cultured with mesangial cells exposed to ATS 50 microl/ml and ATS 50 microl/ml with normal human serum 30 microl/ml, respectively (p < 0.05), while the other groups treated with TGFbeta1 1 ng/ml, TNFalpha 10 ng/ml or IL-1 10 ng/ml had little rise of UCH-L1 expression, with no statistical significance compared with normal control (p > 0.05). Further tests indicated that the percentage of PCNA-positive podocytes in LN, APGN and IgA nephropathy was significantly higher than that in MCD, FSGS and normal control (p < 0.05). These data show for the first time that podocytes do express UCH-L1 and that its expression can be increased in these immunocomplex-mediated nephrites. The immune injury is a main cause for stimulating podocytes to express UCH-L1. The expression of UCH-L1 may be associated with the regeneration of podocytes as a repair response to immunocomplex-mediated injury.
泛素羧基末端水解酶L1(UCH-L1)是参与泛素-蛋白酶体途径的去泛素化酶家族的重要成员,主要在神经和生殖系统以及一些肿瘤中表达。最近,已发现UCH-L1在肾小囊壁层上皮细胞和肾脏的一些肾小管上皮中表达。然而,UCH-L1是否在肾小球毛细血管襻中表达尚不清楚。在本研究中,我们使用免疫组织化学、双重免疫荧光标记、肾活检组织中的免疫电子显微镜以及培养的大鼠足细胞中的蛋白质免疫印迹来研究UCH-L1的表达及其在足细胞中表达的调控。结果表明,UCH-L1在足细胞中表达,并且其在急性增生性肾小球肾炎(APGN)、狼疮性肾炎(LN)、膜性肾小球肾炎(MGN)和IgA肾病中的表达明显高于局灶节段性肾小球硬化(FSGS)、微小病变肾病(MCD)、轻度异常和正常肾脏组织(p<0.05)。在体外实验中,蛋白质免疫印迹显示,分别与暴露于50微升/毫升ATS和50微升/毫升ATS加30微升/毫升正常人血清的系膜细胞共培养的两组足细胞中,UCH-L1表达显著增加(p<0.05),而用1纳克/毫升TGFβ1、10纳克/毫升TNFα或10纳克/毫升IL-1处理的其他组UCH-L1表达几乎没有升高,与正常对照相比无统计学意义(p>0.05)。进一步检测表明,LN、APGN和IgA肾病中PCNA阳性足细胞的百分比显著高于MCD、FSGS和正常对照(p<0.05)。这些数据首次表明足细胞确实表达UCH-L1,并且其表达在这些免疫复合物介导的肾炎中会增加。免疫损伤是刺激足细胞表达UCH-L1的主要原因。UCH-L1的表达可能与足细胞再生有关,作为对免疫复合物介导损伤的一种修复反应。